Virtual Health Care in a Postpandemic World: Implications for Patients With Neuropituitary Disorders

Published:October 06, 2021DOI:https://doi.org/10.1016/j.eprac.2021.09.014
      COVID-19 has led to significant global changes in clinical practice with several health care providers transitioning to virtual health care (VHC); however, the impact of VHC on patients with neuropituitary tumors remains unclear. We sought to assess the impact of VHC on referral patterns of neuropituitary tumors at our center.

      Abbreviation:

      VHC (virtual health care)
      To read this article in full you will need to make a payment
      AACE Member Login
      AACE Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gatto F.
        • Khorrami K.
        • Nista F.
        • Corica G.
        • Ferone D.
        Acromegaly management in a tertiary referral center after 1 year of the coronavirus 2019 pandemic: a double challenge.
        Endocr Pract. 2021; 27: 856-857
        • Rubin R.
        COVID-19’s crushing effects on medical practices, some of which might not survive.
        JAMA. 2020; 324: 321-323
        • Canadian Medical Association
        Virtual Care in Canada: Discussion Paper.
        (Accessed September 18, 2021.)
        • Bhatia R.S.
        • Chu C.
        • Pang A.
        • Tadrous M.
        • Stamenova V.
        • Cram P.
        Virtual care use before and during the COVID-19 pandemic: a repeated cross-sectional study.
        CMAJ Open. 2021; 9: E107-E114